State Of Wyoming Clovis Oncology, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $6,774 - $18,388	-6,452 Reduced 33.2%	12,984 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $8,859 - $41,623	-14,062 Reduced 41.98%	19,436 $35,000
Q1 2022 May 13, 2022	BUY	$1.43 - $3.14 $11,552 - $25,368	8,079 Added 31.78%	33,498 $68,000
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $36,757 - $64,802	13,614 Added 115.32%	25,419 $69,000
Q3 2021 Feb 11, 2022	SELL	$4.06 - $5.8 $962 - $1,374	-237 Reduced 1.97%	11,805 $53,000
Q2 2021 Feb 11, 2022	BUY	$5.02 - $7.05 $60,450 - $84,896	12,042 New	12,042 $70,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.